Comments on: Lilly returns rights to immunology drug after Nektar’s lupus study failure https://lifescivoice.com/lilly-returns-rights-to-immunology-drug-after-nektars-lupus-study-failure/ Life Sciences Voice | The leading resource for life sciences industry executives. Fri, 28 Apr 2023 11:30:49 +0000 hourly 1 https://wordpress.org/?v=6.8.1